GLP‐1 agonists vs placebo
HbA1c (%) · people with diabetes and CKD
1 finding from 1 review
- Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease 2018 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 283 participantsModerate